Robert J. Alpern serves as Executive at ABBOTT LABORATORIES, where they oversee executive responsibilities. Since joining the company, Robert J. Alpern has executed 53 insider transactions totaling $1.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 29, 2011 involved receiving (via award) 2,167 shares valued at $0.
Robert J. Alpern currently holds 10,409 shares of ABBOTT LABORATORIES (ABT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert J. Alpern has been a net seller of ABT stock. They have purchased $0 and sold $1.6M worth of shares.
Robert J. Alpern's most recent insider trade was on Apr 29, 2011, when they sold 2,167 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 24, 2009 | ABT | $0 | Award | 2,465 | $N/A | Discretionary |